基于水凝的治疗与年龄相关的黄斑退化:当前的创新,障碍和未来的前景
Chengzhi Zhang1,2, Jiale Wang1,2, Hao Wu1,2
1Department of Ophthalmology, Henan Eye Institute, Henan Eye Hospital, Henan Provincial People's Hospital (People's Hospital of Zheng Zhou University), Zhengzhou 450003, China.
Gels (Basel, Switzerland)
|March 27, 2024
概括
水凝为与年龄相关的黄斑变性 (AMD) 治疗提供了一个有希望的解决方案. 这些先进的材料使持续的药物输送和细胞植入成为可能,有可能恢复视力并克服当前治疗方法的局限性.
科学领域:
- 眼科和生物材料科学 眼科和生物材料科学
- 眼睛疾病的再生医学.
背景情况:
- 与年龄相关的黄斑变性 (AMD) 导致由于光受体细胞死亡而逐渐失去视力.
- 目前湿性AMD的治疗包括反复注射抗血管内皮生长因子 (anti-VEGF) 药物的眼内注射,这可能会导致并发症的风险.
- 干燥的AMD仍然缺乏有效的治疗方法,这凸显了对创新的治疗策略的需求.
研究的目的:
- 探索水凝作为AMD先进药物输送系统的潜力.
- 审查使用水凝用于持续释放抗VEGF药物和用于AMD治疗中的细胞移植的近期进展.
- 提供水凝特性及其在眼部药物输送中的应用概述.
主要方法:
- 对眼部应用的基于水凝的药物输送系统现有文献的审查.
- 分析水凝特性,包括生物相容性,生物降解性和持续释放能力.
- 检查用于抗VEGF输送和细胞植入策略的水凝利用的最新进展.
主要成果:
- 水凝具有独特的三维聚合物网络,在AMD治疗中具有显著的潜力.
- 已建立的基于水凝的系统在临床前和临床环境中显示出出色的生物相容性和有效性.
- 这些系统通过持续的治疗剂输送和细胞移植,为恢复视力提供了有希望的途径.
结论:
- 基于水凝的输送系统代表了AMD治疗方法的重大进步.
- 它们提供持续释放和促进细胞植入的能力提供了更有效,更少侵入性的治疗选择.
- 预计对水凝技术的进一步研究和改进将导致对AMD的更合理和治愈疗法.
更多相关视频
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.2K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.1K
相关概念视频
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
